Publications
Read their latest work
Article
Hospital internal resource costs and Medicare fee-for-service payment for kidney transplants
02 June 2025 - by Hanaa Siddiqi, Gabriela Dieguez, Charmaine Girdish, Siyi Lu, Carol Bazell
Among kidney transplants in the United States, 64% of procedures were paid for by Medicare, and 90% of patients received induction therapy, according to our analysis for Sanofi U.S.
Article
The evolution of biosimilars in the United States
08 November 2024 - by Jennifer Carioto, Melissa A. Caplen, Hanaa Siddiqi, Ben Diner
Biosimilars recently have made significant strides toward greater acceptance and utilization since their first U.S. approval in 2015, although challenges persist.
Article
How current Part D risk scores could interact with point-of-sale rebates: Recalibration of RxHCCs for POS rebates could have disparate impacts on plan sponsors
24 February 2021 - by Amy Kwong, Bruce S. Pyenson, Feven Asefaha, Hanaa Siddiqi
How current Part D risk scores could interact with point-of-sale rebates.